NCT06915870: Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment
- State
- Completed
- Phase
- No phase
- People
- 108 taking part
- Started
- 12 Jul 2024
- Primary completion
- 13 Jan 2025
- Arms
- In group B, patients were prescribed Empagliflozin 10 mg daily for 12 weeks
- Results
- None posted
- 12 Jul 2024: Trial started
- 13 Jan 2025: Trial completed
- 8 Apr 2025: Trial registered